Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: A multicenter, retrospective study

Authors

Alexandra Rezazadeh, Medical College of Wisconsin
Nancy L. Bartlett, Washington University School of Medicine in St. Louis
et al.

Journal

Haematologica

Publication Date

5-1-2024

Volume

109

Issue

5

First Page

1439

Last Page

1444

Document Type

Open Access Publication

DOI

10.3324/haematol.2023.283210

Rights and Permissions

Rezazadeh A, Szabo A, Khurana A, Inwards DJ, Lunning MA, Bartlett NL, Caimi PF, Rodgers TD, Barr PM, Chowdhury SM, Epperla N, Mendries H, Hill BT, Oh TS, Karmali R, Chang JE, Goyal G, Parsons BM, Isaac KM, Portell CA, Monahan K, Siker M, King DM, Fenske TS. Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study. Haematologica. 2024 May 1;109(5):1439-1444. doi: 10.3324/haematol.2023.283210. ©2024 Ferrata Storti Foundation. Published under a CC BY-NC license.

Recommended Citation

Rezazadeh, Alexandra; Bartlett, Nancy L.; and et al., "Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: A multicenter, retrospective study." Haematologica. 109, 5. 1439 - 1444. (2024).
https://digitalcommons.wustl.edu/oa_4/3893